Results 101 to 110 of about 14,638 (259)
Pharmacology and pharmacokinetics of vitamin E: nanoformulations to enhance bioavailability
, 2020 Vitamin E belongs to the family of lipid-soluble vitamins and can be divided into two groups, tocopherols and tocotrienols, with four isomers (alpha, beta, gamma and delta).
Shiow, Fern Ng +4 more
core +1 more source
Activation of Metal Complexes With Ultrasound Waves for Targeted Anticancer Therapy
Angewandte Chemie International Edition, EarlyView.Ultrasound enables non‐invasive activation of metal‐based therapeutics deep within tumors. Acoustic cavitation can drive sonodynamic reactive oxygen species generation or mechanochemical metal–ligand bond dissociation, enabling controlled release of bioactive payloads.
Félix Grosjean +3 more
wiley +1 more source
Synthesis and Development of Long-Acting Abacavir Prodrug Nanoformulations [PDF]
, 2016 Over the past decade, work from our laboratory has demonstrated the potential of targeted nanoformulated antiretroviral therapy (nanoART) to produce sustained high plasma and tissue drug concentrations for weeks following a single intramuscular (IM ...
Singh, Dhirender
core
Protein-based nanoformulations for α-Tocopherol encapsulation [PDF]
, 2017 Nanoparticles of bovine serum albumin (BSA) and silk fibroin (SF) with entrapped α-tocopherol were produced via ultrasonic emulsification. Populations with particle size of 200300 nm and highly negatively charged were obtained for all the tested ...
Alihosseini, Farzaneh +6 more
core +1 more source
Animal Research and One Health, EarlyView.Antimicrobial resistance (AMR) is an escalating global threat driven by antimicrobial use in aquaculture and livestock. Resistant pathogens and genes can spread across humans, animals, and the environment through interconnected ecosystems. Using a One Health approach, this review emphasizes antimicrobial stewardship, regulatory strengthening, enhanced ...
Mir Mohammad Ali +10 more
wiley +1 more source
Phytomedicine nanoformulations for Parkinson's disease
Background: Current medications for Parkinson's disease (PD) primarily offer symptomatic relief, and often lead to adverse effects on long-term use. This highlights the need for disease-modifying therapies.
Chinthu V. Saji +2 more
core +1 more source
Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy
BMEMat, EarlyView.Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu +5 more
wiley +1 more source
Copper complex nanoformulations featuring highly promising therapeutic potential in murine melanoma models [PDF]
, 2019 Aim: Preclinical evaluation of a cytotoxic copper(II) complex formulated in long circulating nanoliposomes for melanoma treatment. Materials & methods: Liposomal nanoformulations of the copper complex were characterized in terms of thermodynamic behavior
Casini, Angela +6 more
core +1 more source
Nanoencapsulations of essential oils and microbial toxins as insecticides: Case studies for their further optimization [PDF]
Journal of Plant Protection ResearchIndiscriminate use of excessive insecticides has mounted concerns over human health and environmental pollution issues. In contrast, nanoencapsulations of many insecticides can offer a broad range of reliable and mostly safe alternatives based on their ...
Hussein S.A. Salama +2 more
doaj +1 more source
BMEMat, EarlyView.This study provides an integrated spherical nucleic acid nanoreactor (denoted as AMCuD) for targeted PD‐L1 degradation and chemo‐dynamically enhanced cuproptosis to synergically elicit robust immunotherapy against the triple‐negative breast cancer (TNBC) growth, recurrence and metastasis.
Ningxi Li +9 more
wiley +1 more source